医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

NEWS > Home > > 疾病 > AIDS >

China, Share All COVID-19 Data, says AHF

2023年04月01日 AM06:23
このエントリーをはてなブックマークに追加


 

LOS ANGELES

After it was reported that Chinese researchers released “a trove of new genetic data” that can potentially help discern the origin of the COVID-19 pandemic, AIDS Healthcare Foundation (AHF) expressed that while it is a step in the right direction, a full investigation cannot be conducted until China releases all available data it has related to SARS-CoV-2.

“We’re glad that scientists from China’s CDC released this new batch of data that will allow researchers from countries worldwide to analyze for clues on what could’ve started the pandemic,” said AHF Director of Global Advocacy and Policy Guillermina Alaniz. “That said, we’ve had three years of China’s lack of transparency and unwillingness to cooperate by its refusal to grant investigators access to all the information that could determine how the outbreak began. We hope this leads to China uploading more of its data onto platforms like GISAID, which will foster true transparency and cooperation – aspects global public health needed profoundly throughout the pandemic yet didn’t get.”

About AIDS Healthcare Foundation (AHF)

AIDS Healthcare Foundation, the largest global AIDS organization, currently provides medical care and/or services to over 1.7 million people in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230331005436/en/

CONTACT

US MEDIA CONTACT:

Ged Kenslea, Senior Director, Communications, AHF

+1 323 308 1833 work +1.323.791.5526 mobile

gedk@aidshealth.org

Denys Nazarov, Director of Global Policy & Communications, AHF

+1 323.308.1829

denys.nazarov@aidshealth.org

同じカテゴリーの記事 

  • joimax® Obtains Registration for All Products in the Indian Market
  • Avistone Announces the Approval of Vebreltinib as the First MET-TKI Treatment for a Rare Brain Glioma Subtype in China
  • Inocras Pioneers Precision Health with Revolutionary Whole Genome Insights
  • エクセルゲン、バクスター・インターナショナルを提訴。口腔体温計の精度に関するデータの公表権を擁護
  • パース・バイオサイエンシズが研究室用自動化プロバイダー・プログラムをローンチし、ハミルトン、オープントロンズ、ラボワークス、SPTラボテックと提携